Gaku Arai

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

Optimal Sampling Sites for Repeat Prostate Biopsy: A Recursive Partitioning Analysis of Three-Dimensional 26-Core Systematic Biopsy

Satoru Kawakami, Tetsuo Okuno, Junji Yonese et al. · European Urology · 2006 · 76 citations

Medicine, Pathology, Urology +17

Antioxidant cosupplementation therapy with vitamin C, vitamin E, and coenzyme Q10 in patients with oligoasthenozoospermia

Yoshitomo Kobori, Shigeyuki Ota, Ryo Sato et al. · Archivio Italiano di Urologia e Andrologia · 2014 · 67 citations · Full text

Medicine, Pharmacotherapy, Fertility +13

Impaired ΔNp63 expression associates with reduced β-catenin and aggressive phenotypes of urothelial neoplasms

Fumitaka Koga, Satoru Kawakami, Jun Kumagai et al. · British Journal of Cancer · 2003 · 64 citations · Full text

Medicine, Oncology, Pathology +12